Michelle Watson Bunn

Michelle is a managing associate in Ogier Guernsey's Corporate and Funds team. She has extensive experience in a broad range of corporate, commercial, regulatory and investment fund matters and is part of Ogier's multi-disciplinary Private Equity team. Michelle also advises on mergers, acquisitions, disposals, joint ventures, partnerships, debt and equity transactions, listings, financings and investment and shareholder arrangements. She also specialises in structuring advice and fund formation, capital raising, management, special and carry arrangements, operational and administrative requirements (including with respect to parallel, co-investment, employee participation and advisory vehicles) and ongoing fund operation, including regulatory compliance. Michelle also advises clients in relation to Guernsey economic substance requirements, data protection matters and national risk assessments.

Background and experience

Michelle graduated from the University of Exeter with a BA (Hons) in Philosophy. She completed the Graduate Diploma in Law at London Law School in 2006 followed by the Legal Practice Course in 2007. Michelle was admitted as a solicitor in England and Wales in 2009.

Prior to joining Ogier in 2015, Michelle trained and practised with an international law firm in London where she advised publicly traded companies as well as private companies, in addition to advising company directors, company secretaries and in-house counsel on non-transactional company law issues.

Michelle has extensive experience in a broad range of corporate, commercial, regulatory and investment fund matters and is part of Ogier's multi-disciplinary Private Equity team. Michelle advises on mergers, acquisitions, disposals, joint ventures, partnerships, debt and equity transactions, listings, financings and investment and shareholder arrangements. She also specialises in structuring advice and fund formation, capital raising, management, special and carry arrangements, operational and administrative requirements (including with respect to parallel, co-investment, employee participation and advisory vehicles) and ongoing fund operation, including regulatory compliance. Michelle also advises clients in relation to Guernsey economic substance requirements, data protection matters and national risk assessments.

Michelle's achievements in the Private Equity arena include, more recently:

• advising Stanley Capital with the establishment of a Guernsey investment structure and the acquisition of Noden Pharma DAC and Noden Pharma USA, a leading speciality pharmaceutical company in the cardiovascular space;
• advising on a joint venture between Tristan Capital Partners’ CCP 5 Long Life core plus Fund and Cording Real Estate Group on the £245 million acquisition of the Holborn Links Estate from Labtech Investments Limited;
• advising Ogier's long-standing client, Resonance Asset Management, on the launch of its third Guernsey fund, Resonance British Wind Energy Income II Limited, an authorised closed-ended investment fund designated as a Guernsey Green Fund under the Guernsey Green Fund Rules, 2018; and
• advising Merian Chrysalis Investment Company Limited on its establishment, £100 million fund raising and ongoing operations as a registered investment scheme.

Admitted in

2009, England and Wales